836
Views
39
CrossRef citations to date
0
Altmetric
Review

Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions

, MD FESO, , MD & , MD

Bibliography

  • The National Institute of Neurological Disorders and Stroke tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7
  • Barber PA, Zhang J, Demchuk AM, et al. Why are stroke patients excluded from tPA therapy? Analysis of patient eligibility. Neurology 2001;56:1015-20
  • Deng YZ, Reeves MJ, Jacobs BS, et al. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology 2006;66:306-12
  • Erbel R, Alfonso F, Boileau C, et al. Task Force on Aortic Dissection, European Society of Cardiology. Diagnosis and management of aortic dissection. Eur Heart J 2001;22:1642-81
  • Lee SJ, Kim JH, Na CY, et al. Eleven years of experience with the neurologic complications in Korean patients with acute aortic dissection: a retrospective study. BMC Neurol 2013;13:46
  • Gaul C, Dietrich W, Erbguth FJ. Neurological symptoms in aortic dissection: a challenge for neurologists. Cerebrovasc Dis 2008;26:1-8
  • Stanley I, Sharma VK, Tsivgoulis G, et al. Painless aortic dissection with unusual extension into intracranial internal carotid arteries. Cerebrovasc Dis 2007;24:314-15
  • Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122:311-28
  • Marian AJ, Harris SL, Pickett JD, et al. Inadvertent administration of rtPA to a patient with type 1 aortic dissection and subsequent cardiac tamponade. Am J Emerg Med 1993;11:613-15
  • Flemming KD, Brown RDJr. Acute cerebral infarction caused by aortic dissection: caution in the thrombolytic era. Stroke 1999;30:477-8
  • Iguchi Y, Kimura K, Sakai K, et al. Hyper-acute stroke patients associated with aortic dissection. Intern Med 2010;49:543-7
  • Vemmos KN, Spengos K, Tsivgoulis G, et al. Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens 2004;18:253-9
  • Tsivgoulis G, Vadikolias K, Heliopoulos I, et al. Aortic arch dissection causing acute cerebral ischemia: an uncommon contraindication for intravenous thrombolysis. Circulation 2011;124:657-8
  • Hyland MH, Holloway RG. Pearls & Oysters: a stroke of luck: detecting type A aortic dissection by MRA. Neurology 2011;76:e31-3
  • Jauch EC, Saver JL, Adams HPJr, et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947
  • Tsigkas G, Kasimis G, Theodoropoulos K, et al. A successfully thrombolysed acute inferior myocardial infarction due to type A aortic dissection with lethal consequences: the importance of early cardiac echocardiography. J Cardiothorac Surg 2011;6:101
  • Benninger DH, Georgiadis D, Kremer C, et al. Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke 2004;35:482-5
  • Haneline MT, Rosner AL. The etiology of cervical artery dissection. J Chiropr Med 2007;6:110-20
  • Longo GM, Kibbe MR. Aneurysms of the carotid artery. Semin Vasc Surg 2005;18:178-83
  • Zinkstok SM, Vergouwen MD, Engelter ST, et al. Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data. Stroke 2011;42:2515-20
  • Engelter ST, Dallongeville J, Kloss M, et al. Cervical Artery Dissection and Ischaemic Stroke Patients-Study Group. Thrombolysis in cervical artery dissection–data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol 2012;19:1199-206
  • Sato S, Toyoda K, Matsuoka H, et al. Isolated anterior cerebral artery territory infarction: dissection as an etiological mechanism. Cerebrovasc Dis 2010;29:170-7
  • Wilkinson IM. The vertebral artery. Extracranial and intracranial structure. Arch Neurol 1972;27:392-6
  • Kim BM, Kim SH, Kim DI, et al. Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection. Neurology 2011;76:1735-41
  • Caplan LR. Dissections of brain-supplying arteries. Nat Clin Pract Neurol 2008;4:34-42
  • So TY, Mitchell PJ, Dowling RJ, Yan B. Efficacy, complications and clinical outcome of endovascular treatment for intracranial intradural arterial dissections. Clin Neurol Neurosurg 2014;117:6-11
  • Mohammadian R, Taheraghdam AA, Sharifipour E, et al. Endovascular treatment of intracranial artery dissection: clinical and angiographic follow-up. Neurol Res Int 2013;2013:968380
  • Kwak JH, Choi JW, Park HJ, et al. Cerebral artery dissection: spectrum of clinical presentations related to angiographic findings. Neurointervention 2011;6:78-83
  • Leistner S, Hartmann A, Marx P, Koennecke HC. Successful thrombolytic treatment of intracranial carotid occlusion due to dissection. Eur Neurol 2001;45:284-5
  • Fu Y, Komiyama M, Inoue T, et al. A case of middle cerebral artery occlusion caused by dissecting aneurysm. [Article in Japanese]. No Shinkei Geka 1996;24:955-9
  • Ogiwara H, Maeda K, Hara T, et al. Spontaneous intracranial internal carotid artery dissection treated by intra-arterial thrombolysis and superficial temporal artery-middle cerebral artery anastomosis in the acute stage–case report. Neurol Med Chir (Tokyo) 2005;45:148-51
  • Doijiri R, Yokota C, Suzuki R, et al. Intravenous recombinant tissue plasminogen activator thrombolysis in acute ischemic stroke due to middle cerebral artery dissection. J Stroke Cerebrovasc Dis 2012;21:915.e7-9
  • Moon Y, Lee JH, Cho HJ, et al. Intravenous thrombolysis in a patient with acute ischemic stroke attributable to intracranial dissection. Neurologist 2012;18:136-8
  • Shea K, Thompson S, Maud A, Taylor R. Web site of the society of vascular and interventional neurology. Available from: http://www.svin.org/files/Abstract_2.pdf [Last accessed 1 December 2014]
  • Edwards NJ, Kamel H, Josephson SA. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke 2012;43:412-16
  • Chen F, Yan S, Jin X, et al. Post-thrombolysis hemorrhage risk of unruptured intracranial aneurysms. Eur Neurol 2014;73:37-43
  • Rammos SK, Neils DM, Fraser K, Klopfenstein JD. Anterior communicating artery aneurysm rupture after intravenous thrombolysis for acute middle cerebral artery thromboembolism: case report. Neurosurgery 2012;70:E1603-7; discussion E1607
  • Ritter MA, Kloska S, Konrad C, et al. Rupture of a thrombosed intracranial aneurysm during arterial thrombolysis. J Neurol 2003;250:1255-6
  • Ganz W, Geft I, Shah PK, et al. Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol 1984;53:1209-16
  • Lukovits TG, Allen CD. Subarachnoid hemorrhage after thrombolytic therapy for acute myocardial infarction: a case report. J Stroke Cerebrovasc Dis 1996;6:104-5
  • Lagares A, Gómez PA, Lobato RD, et al. Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction. Surg Neurol 1999;52:623-6
  • Matsumaru Y, Hyodo A, Okazaki M, Nose T. A pitfall of fibrinolysis. Aneurysms found after attempted fibrinolytic therapy of occluded arteries. Interv Neuroradiol 1998;4:165-9
  • Chou CL, Lin YJ, Po HL, Chang CK. Subarachnoid hemorrhage–a rare complication after intravenous thrombolysis in an ischemic stroke patient. Am J Emerg Med 2010;28:984.e1-3
  • Gattringer T, Pichler A, Homayoon N, et al. Symptomatic bleeding from an intracerebral cavernoma after intravenous thrombolysis for ischemic stroke. J Neurol 2013;260:1417-19
  • Guillon B, Toulgoat F. Cerebrovascular malformation revealed during the prethrombolysis workup in acute ischemic stroke. Impact on therapeutic decision making. [Article in French]. Rev Neurol (Paris) 2014;170:425-31
  • Erdur H, Scheitz JF, Tütüncü S, et al. Safety of thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformations. Stroke 2014;45:1846-8
  • Proner J, Rosenblum BR, Rothman A. Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator. Arch Neurol 1990;47:105-6
  • Jafar JJ, Tan WS, Crowell RM. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report. J Neurosurg 1991;74:808-12
  • Sloan MA, Price TR, Petito CK, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 1995;45:649-58
  • Sumner CJ, Golden JA, Hemphill JCIII. Should thrombolysis be contraindicated in patients with cerebral arteriovenous malformations? Crit Care Med 2002;30:2359-62
  • Moscato G, Maritato P, Gallerini S, et al. Intra-arterial thrombolysis in basilar artery occlusion and recent haemorrhagic stroke due to arteriovenous malformation. J Clin Neurosci 2004;11:642-4
  • Henninger N, Ahmad N, Morris JG. Intravenous thrombolysis in a patient with known cavernous malformation: a first case report. Am J Emerg Med 2010;28:117.e1-3
  • Katz BS, Flemming KD. Successful IV thrombolysis followed by mechanical thrombectomy in a patient with cerebral ischemia and a dural AV fistula. Am J Emerg Med 2013;31:637.e1-2
  • Herzig R, Bogousslavsky J, Maeder P, et al. Intracranial arterial and arteriovenous malformations presenting with infarction. Lausanne stroke registry study. Eur J Neurol 2005;12:93-102
  • Guillon B, Daumas-Duport B, Delaroche O, et al. Cerebral ischemia complicating intracranial aneurysm: a warning sign of imminent rupture? Am J Neuroradiol 2011;32:1862-5
  • Tsivgoulis G, Vadikolias K, Heliopoulos I, et al. Acute cerebral ischemia owing to unruptured dissecting intracranial aneurysm: an uncommon contraindication for intravenous thrombolysis. Arch Neurol 2010;67:770-1
  • Batjer HH, Devous MDSr, Seibert GB, et al. Intracranial arteriovenous malformation: relationships between clinical and radiographic factors and ipsilateral steal severity. Neurosurgery 1988;23:322-8
  • Komiyama M, Nakajima H, Nishikawa M, et al. Embolic stroke in the territory of a cerebellar arteriovenous malformation–case report. Neurol Med Chir (Tokyo) 1998;38:417-19
  • Otten P, Pizzolato GP, Rilliet B, et al. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 1989;35:82-3; 128-31
  • Batra S, Lin D, Recinos PF, et al. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 2009;5:659-70
  • Kivelev J, Niemelä M, Hernesniemi J. Characteristics of cavernomas of the brain and spine. J Clin Neurosci 2012;19:643-8
  • Murthy S, Moradiya Y, Shah S, et al. Thrombolytic Outcomes for Acute Ischemic Stroke in Patients with Primary Brain Tumors in the United States. Neurology 2014.82:(10 Suppl): P4.220. Available from: https://www.bcm.edu/departments/neurology/pdf/poster_00070.pdf [Last accessed 1 December 2014]
  • Garcia AM, Egido JA, Garcia ME, et al. Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report. BMJ Case Report 2009;2009:pii:bcr06.2008.0268
  • Hsieh HC, Chen CH. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Clin Neurol Neurosurg 2009;111:562-3
  • Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Rep Med 2011;2011:503758
  • Förster A, Griebe M, Wolf ME, et al. How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol 2012;259:1347-53
  • Brunser AM, Illanes S, Lavados PM, et al. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J Stroke Cerebrovasc Dis 2013;22:1140-5
  • Baiense RF, Abrahão A, Ricarte IF, et al. Successful intra-arterial thrombolysis in a patient with an intracranial meningioma. J Stroke Cerebrovasc Dis 2013;22:e658-60
  • Etgen T, Steinich I, Gsottschneider L. Thrombolysis for ischemic stroke in patients with brain tumors. J Stroke Cerebrovasc Dis 2014;23:361-6
  • Dafer RM, Paleologos N, Lynch D. Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report. J Stroke Cerebrovasc Dis 2014;23:1235-8
  • Saver JL. Time is brain–quantified. Stroke 2006;37:263-6
  • Meretoja A, Keshtkaran M, Saver JL, et al. Stroke thrombolysis: save a minute, save a day. Stroke 2014;45:1053-8
  • Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309:2480-8
  • Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke 2011;42:1771-4
  • Zinkstok SM, Engelter ST, Gensicke H, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke 2013;44:1080-4
  • Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010;74:1340-5
  • Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, et al. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc Dis 2012;34:115-20
  • Mehta S, Vora N, Edgell RC, et al. Stroke mimics under the drip-and-ship paradigm. J Stroke Cerebrovasc Dis 2014;23:844-9
  • Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med 2003;42:611-18
  • Grimm SA, DeAngelis LM. Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiforme. Neurology 2007;69:936
  • Knaïssi N, Derex L, Cho TH, et al. The risk of thrombolysis in “stroke mimics”: a case report. Neurol Sci 2011;32:973-5
  • Aleu A, Mellado P, Lichy C, et al. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007;38:417-22
  • Tsivgoulis G, Frey JL, Flaster M, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke 2009;40:3631-4
  • Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European–Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41
  • Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA stroke survey. Circulation 2002;105:1679-85
  • Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Retrospective analysis from safe implementation of thrombolysis in stroke–international stroke thrombolysis register (SITS-ISTR). Stroke 2009;40:2442-9
  • Tsivgoulis G, Saqqur M, Sharma VK, et al. CLOTBUST Investigators. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007;38:961-6
  • Saqqur M, Tsivgoulis G, Molina CA, et al. CLOTBUST Investigators. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology 2008;71:1304-12
  • Mazya M, Egido JA, Ford GA, et al. SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012;43:1524-31
  • Tsivgoulis G, Kotsis V, Giannopoulos S. Intravenous thrombolysis for acute ischaemic stroke: effective blood pressure control matters. Int J Stroke 2011;6:125-7
  • Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke 2011;42:3110-15
  • Bluhmki E, Chamorro A, Davalos A, et al. Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009;8:1095-102
  • Willey JZ, Stillman J, Rivolta JA, et al. Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke 2012;7:202-6
  • Urra X, Ariño H, Llull L, et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis. PLoS One 2013;8:e59420
  • Shi L, Zhang M, Liu H, et al. Safety and outcome of thrombolysis in mild stroke: a meta-analysis. Med Sci Monit 2014;20:2117-24
  • Emberson J, Lees KR, Lyden P, et al. for the Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014. [Epub ahead of print]
  • Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force. Levine SR, Khatri P, Broderick JP, et al. NINDS rt-PA Stroke Trial Investigators. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: part 1: rapidly improving stroke symptoms. Stroke 2013;44:2500-5
  • Sobolewski P, Brola W, Wiszniewska M, et al. Intravenous thrombolysis with rt-PA for acute ischemic stroke within 24h of a transient ischemic attack. J Neurol Sci 2014;340:44-9
  • Alonso de Leciñana M, Fuentes B, Masjuan J, et al. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack. Int J Stroke 2012;7:213-18
  • McKinney JS, Masjuan J, Purroy F, et al. Safety of thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack. J Stroke Cerebrovasc Dis 2012;21:551-4
  • Tsivgoulis G, Sharma VK, Mikulik R, et al. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack. Int J Stroke 2014;9:413-18
  • Gaillard N, Schmidt C, Costalat V, et al. Hemorrhagic risk of recent silent cerebral infarct on prethrombolysis MR imaging in acute stroke. Am J Neuroradiol 2012;33:227-31
  • Lyerly MJ, Houston JT, Boehme AK, et al. Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction. J Stroke Cerebrovasc Dis 2014;23:1657-61
  • Frank B, Grotta JC, Alexandrov AV, et al. VISTA Collaborators. Thrombolysis in stroke despite contraindications or warnings? Stroke 2013;44:727-33
  • Wouters A, Lemmens R, Dupont P, Thijs V. Wake-up stroke and stroke of unknown onset: a critical review. Front Neurol 2014;5:153
  • Mackey J, Kleindorfer D, Sucharew H, et al. Population-based study of wake-up strokes. Neurology 2011;76:1662-7
  • Todo K, Moriwaki H, Saito K, et al. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006;21:367-71
  • Manawadu D, Bodla S, Jarosz J, et al. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke 2013;44:2226-31
  • Manawadu D, Bodla S, Keep J, et al. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke 2013;44:427-31
  • Rimmele DL, Thomalla G. Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update. Front Neurol 2014;5:35
  • Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17
  • Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309
  • Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469-75
  • Mlynash M, Lansberg MG, De Silva DA, et al. Refining the definition of the malignant profile: insights from the DEFUSE EPITHET pooled data set. Stroke 2011;42:1270-5
  • Ma H, Parsons MW, Christensen S, et al. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke 2012;7:74-80
  • Thomalla G, Cheng B, Ebinger M, et al. STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicenter observational study. Lancet Neurol 2011;10:978-86
  • Thomalla G, Fiebach JB, Ostergaard L, et al. WAKE-UP investigators. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke 2014;9:829-36
  • Kang DW, Sohn SI, Hong KS, et al. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke 2012;43:3278-83
  • Honan M, Harrell F, Reimer K, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-67
  • Singh RB, Graeb DA, Fung A, et al. Cardiac rupture complicating cerebral intraarterial thrombolytic therapy. AJNR Am J Neuroradiol 1997;18:1881-3
  • Kasner SE, Villar-Cordova CE, Tong D, et al. Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke. Neurology 1998;50:1857-9
  • Kremen SA, Wu MN, Ovbiagele B. Hemopericardium following intravenous thrombolysis for acute ischemic stroke. Cerebrovasc Dis 2005;20:478-9
  • Sen S, Laowatana S, Lima J, et al. Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry 2004;75:1421-5
  • Stafford PJ, Strachan CJ, Vincent R, et al. Multiple micro-emboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ 1989;299:1310-12
  • Derex L, Nighoghossian N, Perinetti M, et al. Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus. Neurology 2001;57:2122-5
  • Meissner W, Lempert T, Saeuberlich-Knigge S, et al. Fatal embolic myocardial infarction after systemic thrombolysis for stroke. Cerebrovasc Dis 2006;22:213-14
  • Mehdiratta M, Murphy C, Al-Harthi A, et al. Myocardial infarction following t-PA for acute stroke. Can J Neurol Sci 2007;34:417-20
  • Sweta A, Sejal S, Prakash S, et al. Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: an unknown danger. Ann Indian Acad Neurol 2010;13:64-6
  • Wallace EL, Smyth SS. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. J Thromb Thrombolysis 2012;34:548-51
  • Venkatesan EP, Ramadoss K, Balakrishnan R, et al. An unusual complication of stroke thrombolysis. J Postgrad Med 2014;60:341-2
  • Gomez-Beldarrain M, Telleria M, Garcia-Monco JC. Peripheral arterial embolism during thrombolysis for stroke. Neurology 2006;67:1096-7
  • Allan M, Zachariah G, Kordzadeh A, et al. An uncommon complication of acute stroke thrombolysis. BMJ Case Rep 2014;10.1136/bcr-2013-202054
  • Georgiadis D, Engelter S, Tettenborn B, et al. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Circulation 2006;114:237-41
  • Yasaka M, Yamaguchi T, Yonehara T, et al. Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke: a case report. Angiology 1994;45:481-4
  • Korn-Lubetzki I, Farkash R, Pachino RM, et al. Incidence and risk factors of cerebrovascular events following cardiac catheterization. J Am Heart Assoc 2013;2:e000413
  • Cline SL, Kalaria VG, Von der Lohe E, Breall JA. Cerebrovascular complications of Cardiac Catheterization. In: Biller and O’Donnell, eds. Sem Cerebrovasc Dis Stroke, New York, NY Elsevier; 2003;3:194-9
  • Safouris A, Massaut J, Triantafyllou N, et al. Safety of IV thrombolysis in an acute stroke patient anticoagulated with unfractioned heparin. J Neurol 2013;260:2911-12
  • Sankaranarayanan R, Msairi A, Davis GK. Stroke complicating cardiac catheterization – a preventable and treatable complication. J Invasive Cardiol 2007;19:40-5
  • De Marco F, Antonio Fernandez-Diaz J, Lefèvre T, et al. Management of cerebrovascular accidents during cardiac catheterization: immediate cerebral angiography versus early neuroimaging strategy. Catheter Cardiovasc Interv 2007;70:560-8
  • Khatri P, Taylor RA, Palumbo V, et al. Treatment of Acute Stroke after Cardiac Catheterization (TASCC) Study Group. The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol 2008;51:906-11
  • Lyden PD. Code stroke in the cath lab. J Am Coll Cardiol 2008;51:912
  • Dentali F, Riva N, Crowther M, et al. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation 2012;126:2381-91
  • Kate M, Szkotak A, Witt A, et al. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:1351-5
  • Lin SY, Tang SC, Tsai LK, et al. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use. Eur J Neurol 2014;21:1285-91
  • Hill MD, Lye T, Moss H, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003;60:1525-7
  • Engelter ST, Fluri F, Buitrago-Téllez C, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 2005;252:1167-70
  • Fugate JE, Kalimullah EA, Wijdicks EF. Angioedema after tPA: what neurointensivists should know. Neurocrit Care 2012;16:440-3
  • Moellman J. tPA-associated angioedema, rebelem.com. Comment. Available from: http://rebelem.com/tpa-associated-angioedema/#ITEM-1530-5 [Last accessed 1 December 2014]
  • Lee VH, Conners JJ, Cutting S, et al. Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:2139-44
  • Kim SH, Choi SH, Song EC, et al. Spinal subdural hematoma following tissue plasminogen activator treatment for acute ischemic stroke. J Neurol Sci 2008;273:139-41
  • Yeo LL, Lim JS, Sharma VK. Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke. J Neurol Sci 2009;284:190-1
  • Liebkind R, Putaala J, Leppä M, et al. Spinal epidural hematoma as a complication of intravenous thrombolysis in an acute ischemic stroke patient. Case Rep Neurol 2010;2:32-6
  • Yip T, Demaerschalk B. Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke. Neurocrit Care 2005;2:47-8
  • Brownlee WJ, Wu TY, Van Dijck SA, Snow BJ. Upper limb compartment syndrome: an unusual complication of stroke thrombolysis. J Clin Neurosci 2014;21:880-2
  • Belzunegui T, Beaumont C, Clint JL, Cabodevilla A. Massive Hemothorax Following Thrombolysis With rtPA in a Stroke Patient With Undiagnosed Rib Fractures. J Med Cases 2013;4:447-9
  • Sutter R, Bruder E, Weissenburg M, Balestra GM. Thyroid hemorrhage causing airway obstruction after intravenous thrombolysis for acute ischemic stroke. Neurocrit Care 2013;19:381-4
  • An SA, Kim J, Kim SH, Kim WC. Abdominal wall hemorrhage after intravenous thrombolysis for acute ischemic stroke. BMC Neurol 2013;13:6
  • McCloskey M, Masengu A, Shields J, Wiggam MI. Acute stroke in a patient with advanced uraemia: should thrombolysis be given? BMJ Case Rep 2013;10.1136/bcr-2012-007307
  • Sheth SA, Yee AH. Mystery case: an unexpected complication of IV thrombolysis for acute ischemic stroke. Neurology 2013;81:e42-3
  • Leonhardt G, Gaul C, Nietsch HH, et al. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006;21:271-6
  • Del Zotto E, Giossi A, Volonghi I, et al. Ischemic stroke during pregnancy and puerperium. Stroke Res Treat 2011;2011:606780
  • Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke 2007;38:1850-4
  • Amlie-Lefond C, deVeber G, Chan AK, et al. International Pediatric Stroke Study Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009;8:530-6
  • Monagle P, Chalmers E, Chan A, et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:887S-968S
  • Nasr DM, Biller J, Rabinstein AA. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients. Pediatr Neurol 2014;51:624-31
  • Bernard TJ, Rivkin MJ, Scholz K, et al. Thrombolysis in Pediatric Stroke Study. Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial. Stroke 2014;45:2018-23
  • Kernan WN, Ovbiagele B, Black HR, et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236
  • Tsivgoulis G, Krogias C, Georgiadis GS, et al. Safety of early endarterectomy in patients with symptomatic carotid artery stenosis: an international multicenter study. Eur J Neurol 2014;21:1251-7; e75-6
  • Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year: national Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340:1781-7
  • Trouillas P, Derex L, Philippeau F, et al. Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases. Stroke 2004;35:1323-8
  • McPherson CM, Woo D, Cohen PL, et al. Early carotid endarterectomy for critical carotid artery stenosis after thrombolysis therapy in acute ischemic stroke in the middle cerebral artery. Stroke 2001;32:2075-80
  • Crozier JE, Reid J, Welch GH, et al. Early carotid endarterectomy following thrombolysis in the hyperacute treatment of stroke. Br J Surg 2011;98:235-8
  • Sallustio F, Koch G, Rocco A, et al. Safety of early carotid artery stenting after systemic thrombolysis: a single center experience. Stroke Res Treat 2012;2012:904575
  • Bartoli MA, Squarcioni C, Nicoli F, et al. Early carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke. Eur J Vasc Endovasc Surg 2009;37:512-18
  • Block HS, Biller J. Commonly asked questions: thrombolytic therapy in the management of acute stroke. Expert Rev Neurother 2013;13:157-65
  • Shoamanesh A, Kwok CS, Lim PA, Benavente OR. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke 2013;8:348-56
  • Fiehler J, Albers GW, Boulanger JM, et al. MR STROKE Group. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738-44
  • Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013;84:277-80
  • Meretoja A, Putaala J, Tatlisumak T, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010;41:1450-8
  • Saver JL, Barsan WG. Swift or sure?: the acceptable rate of neurovascular mimics among IV tPA-treated patients. Neurology 2010;74:1336-7
  • Meretoja A, Strbian D, Mustanoja S, et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 2012;79:306-13
  • Meretoja A, Weir L, Ugalde M, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology 2013;81:1071-6
  • Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 2012;11:397-404
  • Ebinger M, Winter B, Wendt M, et al. STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014;311:1622-31
  • Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a prehospital acute neurological treatment and optimization of medical care in stroke (PHANTOM-S) substudy. JAMA Neurol 2015;72:25-30
  • Tsivgoulis G, Katsanos AH, Alexandrov AV. Reperfusion therapies of acute ischemic stroke: potentials and failures. Front Neurol 2014;5:215
  • Berkhemer OA, Fransen PS, Beumer D, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20
  • Fessler AJ, Alberts MJ. Stroke treatment with tissue plasminogen activator in the setting of aortic dissection. Neurology 2000;54:1010
  • Ibaraki T, Fukumoto H, Nishimoto Y, et al. Surgical management of acute type A aortic dissection with a complaint of disturbance of consciousness; report of a case. Kyobu Geka 2002;55:1053-6
  • Chua CH, Lien LM, Lin CH, Hung CR. Emergency surgical intervention in a patient with delayed diagnosis of aortic dissection presenting with acute ischemic stroke and undergoing thrombolytic therapy. J Thorac Cardiovasc Surg 2005;130:1222-4
  • Uchino K, Estrera A, Calleja S, et al. Aortic dissection presenting as an acute ischemic stroke for thrombolysis. J Neuroimaging 2005;15:281-3
  • Gaul C, Dietrich W, Friedrich I, et al. Neurological symptoms in type A aortic dissections. Stroke 2007;38:292-7
  • Hong KS, Park SY, Whang SI, et al. Intravenous recombinant tissue plasminogen activator thrombolysis in a patient with acute ischemic stroke secondary to aortic dissection. J Clin Neurol 2009;5:49-52
  • Takeuchi S, Takasato Y, Masaoka H, Otani N. Administration of recombinant tissue plasminogen activator to a case of cerebral infarction in the setting of painless aortic dissection. Neurol India 2009;57:808-9
  • Ramalingam VS, Sinnakirouchenan R, Sudhakar S, Brasch AV. Acute ischemic stroke in aortic dissection: case report and review of literature. Indian J Med Sci 2010;64:385-9
  • Rodríguez-Luna D, Vilar RM, Peinazo M, et al. Intravenous thrombolysis in an elderly patient with acute ischemic stroke masking aortic dissection. J Stroke Cerebrovasc Dis 2011;20:559-61
  • Mendes A, Mendonça T, Sousa A, et al. Stroke secondary to aortic dissection treated with a thrombolytic: a successful case. Neurol Sci 2012;33:107-10
  • Noel M, Short J, Farooq MU. Thrombolytic therapy in a patient with acute ischemic stroke caused by aortic dissection. Clin Neurol Neurosurg 2010;112:695-6
  • Haji F, van Adel B, Avery M, et al. Intracranial aneurysm rupture following intravenous thrombolysis for stroke. Can J Neurol Sci 2014;41:95-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.